Opaleye Management’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-3,668
| Closed | -$148K | – | 49 |
|
|
2021
Q2 | $148K | Buy |
+3,668
| New | +$148K | 0.02% | 47 |
|
|
2020
Q4 | – | Sell |
-48,533
| Closed | -$2.77M | – | 60 |
|
|
2020
Q3 | $2.77M | Hold |
48,533
| – | – | 0.54% | 41 |
|
|
2020
Q2 | $3.58M | Buy |
48,533
+3,230
| +7% | +$238K | 0.72% | 36 |
|
|
2020
Q1 | $2.25M | Buy |
+45,303
| New | +$2.25M | 0.6% | 34 |
|
|
2019
Q2 | – | Sell |
-50,000
| Closed | -$2.65M | – | 47 |
|
|
2019
Q1 | $2.65M | Sell |
50,000
-10,000
| -17% | -$530K | 0.73% | 42 |
|
|
2018
Q4 | $2.82M | Hold |
60,000
| – | – | 1.05% | 30 |
|
|
2018
Q3 | $5.28M | Hold |
60,000
| – | – | 1.34% | 26 |
|
|
2018
Q2 | $6.24M | Buy |
+60,000
| New | +$6.24M | 1.62% | 23 |
|
|
2017
Q2 | – | Sell |
-6,125
| Closed | -$955K | – | 43 |
|
|
2017
Q1 | $955K | Buy |
+6,125
| New | +$955K | 0.48% | 37 |
|
|
2016
Q3 | – | Sell |
-2,150
| Closed | -$443K | – | 46 |
|
|
2016
Q2 | $443K | Buy |
+2,150
| New | +$443K | 0.3% | 47 |
|